Wnt Signaling in Renal Cell Carcinoma
Open accessThe DOI matches its Crossref record; 114 of the 115 references it cites were found in a registry or an index.
Abstract
Renal cell carcinoma (RCC) accounts for 90% of all kidney cancers. Due to poor diagnosis, high resistance to the systemic therapies and the fact that most RCC cases occur sporadically, current research switched its focus on studying the molecular mechanisms underlying RCC. The aim is the discovery of new effective and less toxic anti-cancer drugs and novel diagnostic markers. Besides the PI3K/Akt/mTOR, HGF/Met and VHL/hypoxia cellular signaling pathways, the involvement of the Wnt/β-catenin pathway in RCC is commonly studied. Wnt signaling and its targeted genes are known to actively participate in different biological processes during embryonic development and renal cancer. Recently, studies have shown that targeting this pathway by alternating/inhibiting its intracellular signal transduction can reduce cancer cells viability and inhibit their growth. The targets and drugs identified show promising potential to serve as novel RCC therapeutics and prognostic markers. This review aims to summarize the current status quo regarding recent research on RCC focusing on the involvement of the Wnt/β-catenin pathway and how its understanding could facilitate the identification of potential therapeutic targets, new drugs and diagnostic biomarkers.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures

Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“The Wnt/β-catenin pathway is a well-established oncogenic driver in numerous cancers, including ccRCC, where its aberrant activation is linked to tumor initiation and progression [30–32].”
From PPP1R18-mediated activation of Wnt/β-catenin and EMT is dependent on ERK signaling in clear cell renal cell carcinoma (2026) · cites this paper as [32]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Extracellular vesicles: Exosomes, microvesicles, and friends
Raposo, G., & Stoorvogel, W. (2013) · Journal of Cell Biology · doi:10.1083/jcb.201211138 · Cited by 8,099 · cited 1×
“EXs are 30–100 nm and carry mRNA, miRNA, proteins and signaling molecules [108,109].”
BackgroundBiological properties of extracellular vesicles and their physiological functions
Yáñez‐Mó, M., Siljander, P. R. ‐., Andreu, Z., Bedina Zavec, A., Borràs, F. E., Buzas, E. I., Buzas, K., Casal, E., Cappello, F., Carvalho, J., et al. (2015) · Journal of Extracellular Vesicles · doi:10.3402/jev.v4.27066 · Cited by 5,926 · cited 1×
“EXs are 30–100 nm and carry mRNA, miRNA, proteins and signaling molecules [108,109].”
BackgroundWnt/β-Catenin Signaling: Components, Mechanisms, and Diseases
MacDonald, B. T., Tamai, K., & He, X. (2009) · Developmental Cell · doi:10.1016/j.devcel.2009.06.016 · Cited by 5,583
Wnt/β-Catenin Signaling in Development and Disease
Clevers, H. (2006) · Cell · doi:10.1016/j.cell.2006.10.018 · Cited by 5,568
Wnt/β-catenin signaling and disease
Clevers, H., & Nusse, R. (2012) · Cell · doi:10.1016/j.cell.2012.05.012 · Cited by 5,554
The Wnt Signaling Pathway in Development and Disease
Logan, C. Y., & Nusse, R. (2004) · Annual Review of Cell and Developmental Biology · doi:10.1146/annurev.cellbio.20.010403.113126 · Cited by 5,325
β-catenin is a target for the ubiquitin–proteasome pathway
Aberle, H., Bauer, A., Stappert, J., Kispert, A., & Kemler, R. (1997) · The EMBO Journal · doi:10.1093/emboj/16.13.3797 · Cited by 2,529
WNT signalling pathways as therapeutic targets in cancer
Anastas, J. N., & Moon, R. T. (2013) · Nature Reviews Cancer · doi:10.1038/nrc3419 · Cited by 1,911
Kidney organoids from human iPS cells contain multiple lineages and model human nephrogenesis
Takasato, M., Er, P. X., Chiu, H. S., Maier, B., Baillie, G. J., Ferguson, C., Parton, R. G., Wolvetang, E. J., Roost, M. S., Chuva de Sousa Lopes, S. M., et al. (2015) · Nature · doi:10.1038/nature15695 · Cited by 1,627
Wnt Signaling: Multiple Pathways, Multiple Receptors, and Multiple Transcription Factors
Gordon, M. D., & Nusse, R. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.r600015200 · Cited by 1,333
Exosomes Mediate Stromal Mobilization of Autocrine Wnt-PCP Signaling in Breast Cancer Cell Migration
Luga, V., Zhang, L., Viloria-Petit, A. M., Ogunjimi, A. A., Inanlou, M. R., Chiu, E., Buchanan, M., Hosein, A. N., Basik, M., & Wrana, J. L. (2012) · Cell · doi:10.1016/j.cell.2012.11.024 · Cited by 1,311 · cited 1×
“Furthermore, it was found that EXs can induce the activation of the AKT and Erk1/2 pathways in the cell [111], and in breast cancer cells, EXs mobilize autocrine Wnt-planar cell polarity (Wnt PCP) signaling [112].”
BackgroundTargeting Notch, Hedgehog, and Wnt pathways in cancer stem cells: clinical update
Takebe, N., Miele, L., Harris, P. J., Jeong, W., Bando, H., Kahn, M., Yang, S. X., & Ivy, S. P. (2015) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2015.61 · Cited by 1,298
The global burden of cancer: priorities for prevention
Thun, M. J., DeLancey, J. O., Center, M. M., Jemal, A., & Ward, E. M. (2010) · Carcinogenesis · doi:10.1093/carcin/bgp263 · Cited by 1,091
The -Catenin Destruction Complex
Stamos, J. L., & Weis, W. I. (2013) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a007898 · Cited by 1,062
Can we safely target the WNT pathway?
Kahn, M. (2014) · Nature Reviews Drug Discovery · doi:10.1038/nrd4233 · Cited by 1,034
Active Wnt proteins are secreted on exosomes
Gross, J. C., Chaudhary, V., Bartscherer, K., & Boutros, M. (2012) · Nature Cell Biology · doi:10.1038/ncb2574 · Cited by 1,024
International Variations and Trends in Renal Cell Carcinoma Incidence and Mortality
Znaor, A., Lortet-Tieulent, J., Laversanne, M., Jemal, A., & Bray, F. (2015) · European Urology · doi:10.1016/j.eururo.2014.10.002 · Cited by 984
VHL, the story of a tumour suppressor gene
Gossage, L., Eisen, T., & Maher, E. R. (2015) · Nature Reviews Cancer · doi:10.1038/nrc3844 · Cited by 774
An Updated Overview on Wnt Signaling Pathways: A Prelude for More
Rao, T. P., & Kühl, M. (2010) · Circulation Research · doi:10.1161/circresaha.110.219840 · Cited by 638
Wnt signaling: is the party in the nucleus?
Willert, K., & Jones, K. A. (2006) · Genes & Development · doi:10.1101/gad.1424006 · Cited by 589
The Wnt signaling pathway in cancer
Duchartre, Y., Kim, Y.-M., & Kahn, M. (2016) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2015.12.005 · Cited by 548
Majumdar, A., Vainio, S., Kispert, A., McMahon, J., & McMahon, A. P. (2003) · Development · doi:10.1242/dev.00520 · Cited by 482
Self-citationAnticancer drug targets: cell cycle and checkpoint control
Shapiro, G. I., & Harper, J. W. (1999) · Journal of Clinical Investigation · doi:10.1172/jci9054 · Cited by 464
Yao, D., Dai, C., & Peng, S. (2011) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-10-0568 · Cited by 455
Transformation by Wnt family proteins correlates with regulation of beta-catenin.
Shimizu, H., Julius, M. A., Giarrè, M., Zheng, Z., Brown, A. M. C., & Kitajewski, J. (1997) · PubMed · Cited by 409
Hypoxia, Hypoxia-inducible Transcription Factors, and Renal Cancer
Schödel, J., Grampp, S., Maher, E. R., Moch, H., Ratcliffe, P. J., Russo, P., & Mole, D. R. (2016) · European Urology · doi:10.1016/j.eururo.2015.08.007 · Cited by 405
WNT-1 Signaling Inhibits Apoptosis by Activating β-Catenin/T Cell Factor–Mediated Transcription
Chen, S., Guttridge, D. C., You, Z., Zhang, Z., Fribley, A., Mayo, M. W., Kitajewski, J., & Wang, C.-Y. (2001) · The Journal of Cell Biology · doi:10.1083/jcb.152.1.87 · Cited by 394
Wnt-5A/Ror2 Regulate Expression of XPAPC through an Alternative Noncanonical Signaling Pathway
Schambony, A., & Wedlich, D. (2007) · Developmental Cell · doi:10.1016/j.devcel.2007.02.016 · Cited by 310
Gumz, M. L., Zou, H., Kreinest, P. A., Childs, A. C., Belmonte, L. S., LeGrand, S. N., Wu, K. J., Luxon, B. A., Sinha, M., Parker, A. S., et al. (2007) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-07-0143 · Cited by 297
Tissue Interactions Regulating Tooth Development and Renewal
Balic, A., & Thesleff, I. (2015) · Current Topics in Developmental Biology · doi:10.1016/bs.ctdb.2015.07.006 · Cited by 295
Next-generation sequencing to guide cancer therapy
Gagan, J., & Van Allen, E. M. (2015) · Genome Medicine · doi:10.1186/s13073-015-0203-x · Cited by 280
Wnt Signaling in Skin Development, Homeostasis, and Disease
Lim, X., & Nusse, R. (2013) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a008029 · Cited by 268
Jussila, M., & Thesleff, I. (2012) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a008425 · Cited by 263
Signaling pathways in renal cell carcinoma
Banumathy, G., & Cairns, P. (2010) · Cancer Biology & Therapy · doi:10.4161/cbt.10.7.13247 · Cited by 221
Canonical Wnt signaling is antagonized by noncanonical Wnt5a in hepatocellular carcinoma cells
Yuzugullu, H., Benhaj, K., Ozturk, N., Senturk, S., Celik, E., Toylu, A., Tasdemir, N., Yilmaz, M., Erdal, E., Akcali, K. C., et al. (2009) · Molecular Cancer · doi:10.1186/1476-4598-8-90 · Cited by 215 · cited 1×
“While Wnt1 and Wnt10a are canonical Wnts, Wnt5a and Wnt7a belong to the non-canonical group [49,50].”
BackgroundDissociation of embryonic kidneys followed by reaggregation allows the formation of renal tissues
Unbekandt, M., & Davies, J. A. (2010) · Kidney International · doi:10.1038/ki.2009.482 · Cited by 209
Urakami, S., Shiina, H., Enokida, H., Kawakami, T., Tokizane, T., Ogishima, T., Tanaka, Y., Li, L.-C., Ribeiro-Filho, L. A., Terashima, M., et al. (2006) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-05-1344 · Cited by 189
Multiple functions of the noncanonical Wnt pathway
Gómez‐Orte, E., Sáenz‐Narciso, B., Moreno, S., & Cabello, J. (2013) · Trends in Genetics · doi:10.1016/j.tig.2013.06.003 · Cited by 175
HISTOPATHOLOGY AND MOLECULAR GENETICS OF RENAL TUMORS: TOWARD UNIFICATION OF A CLASSIFICATION SYSTEM
ZAMBRANO, N. R., LUBENSKY, I. A., MERINO, M. J., LINEHAN, W. M., & WALTHER, M. M. (1999) · Journal of Urology · doi:10.1016/s0022-5347(05)68259-6 · Cited by 167
The role of WNT signaling in adult ovarian folliculogenesis
Gifford, J. A. H. (2015) · Reproduction · doi:10.1530/rep-14-0685 · Cited by 166
Furge, K. A., Chen, J., Koeman, J., Swiatek, P., Dykema, K., Lucin, K., Kahnoski, R., Yang, X. J., & Teh, B. T. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-4571 · Cited by 151
Genistein downregulates onco-miR-1260b and inhibits Wnt-signalling in renal cancer cells
Hirata, H., Ueno, K., Nakajima, K., Tabatabai, Z. L., Hinoda, Y., Ishii, N., & Dahiya, R. (2013) · British Journal of Cancer · doi:10.1038/bjc.2013.173 · Cited by 143
Targeting the Wnt pathways for therapies
Blagodatski, A., Poteryaev, D., & Katanaev, V. L. (2014) · Molecular and Cellular Therapies · doi:10.1186/2052-8426-2-28 · Cited by 141
Anticancer drug targets: approaching angiogenesis
Keshet, E., & Ben‐Sasson, S. A. (1999) · Journal of Clinical Investigation · doi:10.1172/jci8849 · Cited by 135
Ueda, M., Gemmill, R. M., West, J., Winn, R., Sugita, M., Tanaka, N., Ueki, M., & Drabkin, H. A. (2001) · British Journal of Cancer · doi:10.1054/bjoc.2001.1863 · Cited by 132
Ror2, a developmentally regulated kinase, promotes tumor growth potential in renal cell carcinoma
Wright, T. M., Brannon, A. R., Gordan, J. D., Mikels, A. J., Mitchell, C., Chen, S., Espinosa, I., van de Rijn, M., Pruthi, R., Wallen, E., et al. (2009) · Oncogene · doi:10.1038/onc.2009.116 · Cited by 116
Targeting Wnts at the Source—New Mechanisms, New Biomarkers, New Drugs
Madan, B., & Virshup, D. M. (2015) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-14-1038 · Cited by 114
Signaling pathways in breast cancer: Therapeutic targeting of the microenvironment
Kamdje, A. H. N., Etet, P. F. S., Vecchio, L., Jm, M., Krampera, M., & Lukong, K. E. (2014) · Cellular Signalling · doi:10.1016/j.cellsig.2014.07.034 · Cited by 112
Wnt Signaling in Neuromuscular Junction Development
Koles, K., & Budnik, V. (2012) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a008045 · Cited by 106
Toschi, L., & Jänne, P. A. (2008) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-08-0071 · Cited by 103
Role of DNA methylation in renal cell carcinoma
Shenoy, N., Vallumsetla, N., Zou, Y., Galeas, J. N., Shrivastava, M., Hu, C., Susztak, K., & Verma, A. (2015) · Journal of Hematology & Oncology · doi:10.1186/s13045-015-0180-y · Cited by 102
Du, T., Ju, G., Wu, S., Cheng, Z., Cheng, J., Zou, X., Zhang, G., Miao, S., Liu, G., & Zhu, Y. (2014) · PLoS ONE · doi:10.1371/journal.pone.0096836 · Cited by 100
Peruzzi, B., Athauda, G., & Bottaro, D. P. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0606850103 · Cited by 95
Targeted therapy for advanced renal cell carcinoma
Coppin, C., Le, L., Wilt, T. J., & Kollmannsberger, C. (2008) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd006017.pub2 · Cited by 95
Wnt/β-catenin signaling in the dental mesenchyme regulates incisor development by regulating Bmp4
Fujimori, S., Novak, H., Weißenböck, M., Jussila, M., Gonçalves, A., Zeller, R., Galloway, J. L., Thesleff, I., & Hartmann, C. (2010) · Developmental Biology · doi:10.1016/j.ydbio.2010.09.009 · Cited by 90
Prunskaite‐Hyyryläinen, R., Skovorodkin, I., Xu, Q., Miinalainen, I., Shan, J., & Vainio, S. J. (2015) · Human Molecular Genetics · doi:10.1093/hmg/ddv621 · Cited by 86
Self-citationFunctional Significance of Wnt Inhibitory Factor-1 Gene in Kidney Cancer
Kawakami, K., Hirata, H., Yamamura, S., Kikuno, N., Saini, S., Majid, S., Tanaka, Y., Kawamoto, K., Enokida, H., Nakagawa, M., et al. (2009) · Cancer Research · doi:10.1158/0008-5472.can-09-2534 · Cited by 80
Wnt signaling pathways in urological cancers: past decades and still growing
Majid, S., Saini, S., & Dahiya, R. (2012) · Molecular Cancer · doi:10.1186/1476-4598-11-7 · Cited by 79
Zhang, L., Bhasin, M., Schor-Bardach, R., Wang, X., Collins, M. P., Panka, D. J., Putheti, P., Signoretti, S., Alsop, D. C., Libermann, T. A., et al. (2011) · PLoS ONE · doi:10.1371/journal.pone.0019144 · Cited by 78
Shiina, H., Igawa, M., Breault, J. E., Ribeiro‐Filho, L. A., Pookot, D., Urakami, S., Terashima, M., Deguchi, M., Yamanaka, M., Shirai, M., et al. (2003) · PubMed · Cited by 78
Arai, E., Sakamoto, H., Ichikawa, H., Totsuka, H., Chiku, S., Gotoh, M., Mori, T., Nakatani, T., Ohnami, S., Nakagawa, T., et al. (2014) · International Journal of Cancer · doi:10.1002/ijc.28768 · Cited by 75
Kruck, S., Eyrich, C., Scharpf, M., Sievert, K.-D., Fend, F., Stenzl, A., & Bedke, J. (2013) · International Journal of Molecular Sciences · doi:10.3390/ijms140610944 · Cited by 70
WNT10A Plays an Oncogenic Role in Renal Cell Carcinoma by Activating WNT/β-catenin Pathway
Hsu, R.-J., Ho, J.-Y., Cha, T.-L., Yu, D.-S., Wu, C.-L., Huang, W.-P., Chu, P., Chen, Y.-H., Chen, J.-T., & Yu, C.-P. (2012) · PLoS ONE · doi:10.1371/journal.pone.0047649 · Cited by 70
Mizushima, T., Nakagawa, H., Kamberov, Y. G., Wilder, E. L., Klein, P. S., & Rustgi, A. K. (2002) · PubMed · Cited by 69
Prunskaite‐Hyyryläinen, R., Shan, J., Railo, A., Heinonen, K. M., Miinalainen, I., Yan, W., Shen, B., Perreault, C., & Vainio, S. J. (2013) · The FASEB Journal · doi:10.1096/fj.13-233247 · Cited by 68
Self-citationRole of Wnt5a-Ror2 Signaling in Morphogenesis of the Metanephric Mesenchyme during Ureteric Budding
Nishita, M., Qiao, S., Miyamoto, M., Okinaka, Y., Yamada, M., Hashimoto, R., Iijima, K., Otani, H., Hartmann, C., Nishinakamura, R., et al. (2014) · Molecular and Cellular Biology · doi:10.1128/mcb.00491-14 · Cited by 66
Ueno, K., Hirata, H., Majid, S., Tabatabai, Z. L., Hinoda, Y., & Dahiya, R. (2011) · International Journal of Cancer · doi:10.1002/ijc.25899 · Cited by 63
Current approaches in identification and isolation of human renal cell carcinoma cancer stem cells
Khan, M. I., Czarnecka, A. M., Helbrecht, I., Bartnik, E., Lian, F., & Szczylik, C. A. (2015) · Stem Cell Research & Therapy · doi:10.1186/s13287-015-0177-z · Cited by 63
Wnt antagonist DICKKOPF‐3 (Dkk‐3) induces apoptosis in human renal cell carcinoma
Ueno, K., Hirata, H., Majid, S., Chen, Y., Zaman, M. S., Tabatabai, Z. L., Hinoda, Y., & Dahiya, R. (2011) · Molecular Carcinogenesis · doi:10.1002/mc.20729 · Cited by 61
Afelik, S., Pool, B., Schmerr, M., Penton, C. M., & Jensen, J. N. (2015) · Developmental Biology · doi:10.1016/j.ydbio.2014.12.031 · Cited by 61
Smith, B. H., Gazda, L. S., Conn, B. L., Jain, K., Asina, S., Levine, D. M., Parker, T. S., Laramore, M. A., Martis, P. C., Vinerean, H. V., et al. (2011) · Cancer Research · doi:10.1158/0008-5472.can-10-2254 · Cited by 59
Wnt4 is essential to normal mammalian lung development
Caprioli, A., Villasenor, A., Wylie, L. A., Braitsch, C. M., Marty‐Santos, L., Barry, D., Karner, C. M., Fu, S., Meadows, S. M., Carroll, T. J., et al. (2015) · Developmental Biology · doi:10.1016/j.ydbio.2015.08.017 · Cited by 58
Wnt antagonist gene polymorphisms and renal cancer
Hirata, H., Hinoda, Y., Nakajima, K., Kikuno, N., Yamamura, S., Kawakami, K., Suehiro, Y., Tabatabai, Z. L., Ishii, N., & Dahiya, R. (2009) · Cancer · doi:10.1002/cncr.24491 · Cited by 58
Kawamoto, K., Hirata, H., Kikuno, N., Tanaka, Y., Nakagawa, M., & Dahiya, R. (2008) · International Journal of Cancer · doi:10.1002/ijc.23514 · Cited by 56
Differential expression of canonical and non‐canonical Wnt ligands in ameloblastoma
Siar, C. H., Nagatsuka, H., Han, P. P., Buery, R. R., Tsujigiwa, H., Nakano, K., Ng, K. H., & Kawakami, T. (2011) · Journal of Oral Pathology and Medicine · doi:10.1111/j.1600-0714.2011.01104.x · Cited by 56
Targeting the Wnt/beta-catenin pathway in renal cell carcinoma.
Schulz-Hausmann, S. A. V., Schmeel, L. C., Schmeel, F. C., & Schmidt‐Wolf, I. G. H. (2014) · PubMed · Cited by 56
Bilim, V. N., Kawasaki, T., Katagiri, A., Wakatsuki, S., Takahashi, K., & Tomita, Y. (2000) · PubMed · Cited by 54
Krause, M., Samoylenko, A., & Vainio, S. J. (2015) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2015.00065 · Cited by 54
Self-citationProgression of renal cell carcinoma is inhibited by genistein and radiation in an orthotopic model
Hillman, G. G., Wang, Y., Che, M., Raffoul, J. J., Yudelev, M., Kucuk, O., & Sarkar, F. H. (2007) · BMC Cancer · doi:10.1186/1471-2407-7-4 · Cited by 53
β‐Catenin expression and mutational analysis in renal cell carcinomas
Kim, Y., Kang, Y. K., Kim, J. B., Han, S. A., Kim, K. I., & Paik, S. R. (2000) · Pathology International · doi:10.1046/j.1440-1827.2000.01111.x · Cited by 53
Kawakami, K., Yamamura, S., Hirata, H., Ueno, K., Saini, S., Majid, S., Tanaka, Y., Kawamoto, K., Enokida, H., Nakagawa, M., et al. (2010) · International Journal of Cancer · doi:10.1002/ijc.25357 · Cited by 53
Antiproliferative and antiangiogenic activities of genistein in human renal cell carcinoma
Sasamura, H., Takahashi, A., Yuan, J., Kitamura, H., Masumori, N., Miyao, N., Itoh, N., & Tsukamoto, T. (2004) · Urology · doi:10.1016/j.urology.2004.03.045 · Cited by 51
Nephrogenesis regulated by Wnt signaling
Vainio, S. J. (2003) · Journal of Nephrology · doi:10.1093/joneph/16.2.279 · Cited by 51
Self-citationThe complex roles of Wnt antagonists in RCC
Saini, S., Majid, S., & Dahiya, R. (2011) · Nature Reviews Urology · doi:10.1038/nrurol.2011.146 · Cited by 50
The Advantages and Disadvantages of Sfrp1 and Sfrp2 Expression in Pathological Events
Esteve, P., & Bovolenta, P. (2010) · The Tohoku Journal of Experimental Medicine · doi:10.1620/tjem.221.11 · Cited by 49
Oncogenic Functions of Secreted Frizzled-Related Protein 2 in Human Renal Cancer
Yamamura, S., Kawakami, K., Hirata, H., Ueno, K., Saini, S., Majid, S., & Dahiya, R. (2010) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-10-0012 · Cited by 49
Alteration of Frizzled Expression in Renal Cell Carcinoma
Janssens, N., Andries, L. J., Janicot, M., Perera, T., & Bakker, A. C. (2004) · Tumor Biology · doi:10.1159/000081098 · Cited by 49
Identification of the genes regulated by Wnt-4, a critical signal for commitment of the ovary
Naillat, F., Yan, W., Karjalainen, R., Liakhovitskaia, A., Samoylenko, A., Xu, Q., Sun, Z., Shen, B., Medvinsky, A., Quaggin, S. E., et al. (2015) · Experimental Cell Research · doi:10.1016/j.yexcr.2015.01.010 · Cited by 47
Self-citationOrganIn VitroCulture: What Have We Learned about Early Kidney Development?
Rak‐Raszewska, A., Hauser, P., & Vainio, S. J. (2015) · Stem Cells International · doi:10.1155/2015/959807 · Cited by 45
Self-citationGuillen-Ahlers, H. (2008) · Current Drug Targets · doi:10.2174/138945008784911813 · Cited by 43
Alterations of the WNT7A Gene in Clear Cell Renal Cell Carcinomas
Kondratov, O., Kvasha, S. M., Stoliar, L. A., Am, R., Zgonnyk, Y. M., Gordiyuk, V. V., Kashuba, E., Rynditch, A. V., Zabarovsky, E. R., & Kashuba, V. I. (2012) · PLoS ONE · doi:10.1371/journal.pone.0047012 · Cited by 41
miR-124 represses FZD5 to attenuate P-glycoprotein-mediated chemo-resistance in renal cell carcinoma
Long, Q., Du, Y., Liu, X., Li, X., & He, D. (2015) · Tumor Biology · doi:10.1007/s13277-015-3369-3 · Cited by 41
Hirata, H., Hinoda, Y., Majid, S., Chen, Y., Zaman, M. S., Ueno, K., Nakajima, K., Tabatabai, Z. L., Ishii, N., & Dahiya, R. (2010) · Cancer · doi:10.1002/cncr.25666 · Cited by 41
Functional Genetic Targeting of Embryonic Kidney Progenitor Cells Ex Vivo
Junttila, S., Saarela, U., Halt, K., Manninen, A., Pärssinen, H., Lecca, M. R., Brändli, A. W., Sims‐Lucas, S., Skovorodkin, I., & Vainio, S. J. (2014) · Journal of the American Society of Nephrology · doi:10.1681/asn.2013060584 · Cited by 40
Self-citationGeneration of an allele to inactivate Wnt4 gene function conditionally in the mouse
Shan, J., Jokela, T. A., Peltoketo, H., & Vainio, S. J. (2009) · genesis · doi:10.1002/dvg.20566 · Cited by 39
Self-citationWNT5A Is Regulated by PAX2 and May Be Involved in Blastemal Predominant Wilms Tumorigenesis
Tamimi, Y., Ekuere, U., Laughton, N., & Grundy, P. E. (2008) · Neoplasia · doi:10.1593/neo.08442 · Cited by 38
Decreased expression of Dkk1 and Dkk3 in human clear cell renal cell carcinoma
Guo, C., Zhang, X., Yang, B., Geng, J., Peng, B., & Zheng, J. (2014) · Molecular Medicine Reports · doi:10.3892/mmr.2014.2077 · Cited by 36
Yang, Z., Balic, A., Michon, F., Juuri, E., & Thesleff, I. (2015) · Stem Cells · doi:10.1002/stem.1972 · Cited by 32
Ho, J., Hsu, R., Wu, C., Chang, W.-L., Cha, T., Yü, D., & Yu, C. (2013) · Evidence-based Complementary and Alternative Medicine · doi:10.1155/2013/161628 · Cited by 32
Pietilä, I., Prunskaite‐Hyyryläinen, R., Kaisto, S., Tika, E., van Eerde, A. M., Salo, A. M., Garma, L. D., Miinalainen, I., Feitz, W., Bongers, E. M. H. F., et al. (2016) · PLoS ONE · doi:10.1371/journal.pone.0147171 · Cited by 32
Self-citationWnt-Signalling in the Embryonic Mammary Gland
Boras-Granic, K., & Hamel, P. A. (2013) · Journal of Mammary Gland Biology and Neoplasia · doi:10.1007/s10911-013-9280-x · Cited by 30
Wnt5a Is Necessary for Normal Kidney Development in Zebrafish and Mice
Huang, L., Xiao, A., Choi, S. Y., Kan, Q., Zhou, W., Chacon-Heszele, M. F., Ryu, Y. K., McKenna, S., Zuo, X., Kuruvilla, R., et al. (2014) · Nephron Experimental Nephrology · doi:10.1159/000368411 · Cited by 30
Expression of Ror2 Mediates Invasive Phenotypes in Renal Cell Carcinoma
Rasmussen, N. R., Debebe, Z., Wright, T. M., Brooks, S. A., Sendor, A. B., Brannon, A. R., Hakimi, A. A., Hsieh, J. J.-D., Choueiri, T. K., Tamboli, P., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0116101 · Cited by 29
Konaç, E., Varol, N., Yılmaz, A., Menevşe, S., & Sözen, S. (2013) · Experimental Biology and Medicine · doi:10.1177/1535370213498984 · Cited by 28
Targeting Prostate Cancer with a Combination of WNT Inhibitors and a Bi-functional Peptide
MESSINA, C. S., Weiher, H., & Schmidt‐Wolf, I. G. H. (2017) · Anticancer Research · doi:10.21873/anticanres.11348 · Cited by 26
Advances in the Genetics of Familial Renal Cancer
Morrison, P. J., Donnelly, D. E., Atkinson, A. B., & Maxwell, A. P. (2010) · The Oncologist · doi:10.1634/theoncologist.2010-0023 · Cited by 23
Kruck, S., Eyrich, C., Scharpf, M. O., Sievert, K., Fend, F., Stenzl, A., & Bedke, J. (2013) · International Journal of Molecular Sciences · Cited by 23
Loss of heterozygosity and SOSTDC1 in adult and pediatric renal tumors
Blish, K. R., Clausen, K. A., Hawkins, G. A., Garvin, A. J., Willingham, M. C., Turner, J. C., Torti, F. M., & Torti, S. V. (2010) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/1756-9966-29-147 · Cited by 20
The expression and function of Frizzled-7 in human renal cell carcinoma
Xu, R., Zeng, S., Xie, W., Sun, C., Chen, Y., CHEN, M., & Zhang, L. (2015) · Clinical & Translational Oncology · doi:10.1007/s12094-015-1362-3 · Cited by 19
Renal carcinogenesis--insights into signaling pathways.
Cojocaru, E., Lozneanu, L., Giuşcă, S. E., Căruntu, I.-D., & Danciu, M. (2015) · PubMed · Cited by 19
Zhang, H., Zhou, W., Li, X., Meng, W. B., Zhang, L., Zhu, X., Zhu, K., Bai, Z.-M., Yan, J., Liu, T., et al. (2014) · Genetics and Molecular Research · doi:10.4238/2014.july.4.22 · Cited by 17
[A role of WNT in kidney development and function].
Mesar, I., Kes, P., & Bašić‐Jukić, N. (2012) · Acta medica Croatica · Cited by 5
Роль сигнального пути Wnt в регуляции работы мозга
Gurskaya, O., Добрякова, Ю. В., & Маркевич, В. А. (2015) · Журнал высшей нервной деятельности им И П Павлова · doi:10.7868/s0044467715040048 · Cited by 4
[A Role of the Wnt Signaling in the Regulation of Brain Function].
Oy, G., Yv, D., & Markevich, V. A. (2015) · PubMed · Cited by 2
Cited by
Wnt/β-catenin signaling pathway in carcinogenesis and cancer therapy
Song, P., Gao, Z., Bao, Y., Chen, L., Huang, Y., Liu, Y., Dong, Q., & Wei, X. (2024) · Journal of Hematology & Oncology · doi:10.1186/s13045-024-01563-4 · Cited by 382
“Cytoplasmic accumulation of β-catenin is considered a promising therapeutic approach due to their potential role in maintaining cellular homeostasis [256].”
BackgroundMiT/TFE Family of Transcription Factors, Lysosomes, and Cancer
Perera, R. M., Di Malta, C., & Ballabio, A. (2019) · Annual Review of Cancer Biology · doi:10.1146/annurev-cancerbio-030518-055835 · Cited by 157
Inamura, K. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18102195 · Cited by 162
Causal integration of multi‐omics data with prior knowledge to generate mechanistic hypotheses
Dugourd, A., Kuppe, C., Sciacovelli, M., Gjerga, E., Gabor, A., Emdal, K. B., Vieira, V., Bekker‐Jensen, D. B., Kranz, J., Bindels, E. M. J., et al. (2021) · Molecular Systems Biology · doi:10.15252/msb.20209730 · Cited by 149
Shah, K., Panchal, S., & Patel, B. (2021) · Pharmacological Research · doi:10.1016/j.phrs.2021.105532 · Cited by 118
Metadata
- Authors
- Xu, Q., Krause, M., Samoylenko, A., & Vainio, S.
- Affiliations
- University of Oulu (FI)
- Corresponding author
- Vainio, Seppo
- Venue
- Cancers
- Publisher
- MDPI AG
- Published
- 2016-06-17
- Volume
- 8
- Issue
- 6
- Pages
- 57
- ISSN
- 2072-6694 (ISSN-L)
- PMC
- PMC4931622
- OpenAlex
- W2440181709
- Cited by
- 99
- References
- 115
- Citations by year
- 2026: 4 · 2025: 8 · 2024: 15 · 2023: 7 · 2022: 8 · 2021: 12 · 2020: 18 · 2019: 7 · 2018: 4 · 2017: 16
- FWCI
- 0.81
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- Cancers (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- Academy of Finland (206038, 121647)
- Academy of Finland Centre of Excellence (251314)
- FiDiPro (S.Q. 263246)
- the European Community's Seventh Framework Programme (EURenOmics 305608)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Wnt/β-catenin signaling in development and cancer
- Health Sciences › Medicine › Oncology › Renal cell carcinoma treatment
- Health Sciences › Medicine › Oncology › Renal and related cancers
- Keywords
- renal cell carcinoma, Wnt/β-catenin signaling, therapeutic target, diagnostic biomarkers, prognostic factors, PI3K/AKT/mTOR pathway, HGF/MET pathway, signal transduction inhibition, anticancer agents
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.